الفهرس | Only 14 pages are availabe for public view |
Abstract The purpose of this thesis was to evaluate the difference in the efficacy and safety of misoprostol ”PGE1, analogue” when given orally or vaginally in the termination of midtrimester intrauterine fetal death at gestational age 16: 26 weeks. This study was conducted during the period from May 2003 to January 2004, in 40 women divided randomly into two equal groups. |